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Abstract
Background: Members of Rhizopus species are the most common cause of mucormycosis, a rare but often fatal
fungal infection. Host induced pathogen apoptosis and pathogen induced host cell apoptosis are often involved in
fungal infections. In many organisms, the release of mitochondrial cytochrome c can trigger apoptosis by activating
caspase proteases, but the role of fungal cytochrome c in apoptosis remains unknown.
Results: DNA sequence encoding Rhizopus arrhizus cytochrome c was cloned and expressed in E. coli. Both native
and recombinant cytochrome c were purified using ion exchange followed by gel filtration chromatography. The
identities of purified proteins were confirmed by MALDI-MS and UV-Visible spectroscopy. For the first time, we
demonstrated that Rhizopus arrhizus cytochrome c could activate human capspase-3 in HeLa cell extracts. We also
found that Rhizopus arrhizus cytochrome c has redox potential, peroxidase activity, and spectral properties similar to
human and horse cytochrome c proteins.
Conclusions: Rhizopus arrhizus cytochrome c can activate human caspase-3 in HeLa cell extracts and it possesses
similar physical and spectral properties as human and horse cytochrome c. This protein was found to have a
previously unknown potential to activate human caspase-3, an important step in the apoptosis cascade.
Background
Mucormycosis are rare but often life-threatening infec-
tions seen in immunocompromised, diabetic, and organ
transplant patients [1]. These infections are difficult to
treat and with an increase in the number of diabetic pa-
tients and organ transplants, in the future such infections
are likely to increase [1, 2]. Rhizopus spp. accounts for the
majority of the mucormycosis infections [1]. Results in re-
cent decades suggest that apoptosis may play an important
role in both establishment and clearance of fungal infec-
tions [3]. In response to fungal infections, the oxidative
burst by host immune cells could help in infection clear-
ance by triggering apoptosis in the fungus [4, 5]. Also,
pathogen-induced apoptosis in host immune cells could
help the pathogen to establish the infection [6]. Thus, the
success of an infection partly depends on the outcome of
such host pathogen interactions. It has been shown that ex-
tracts from the filamentous fungus could induce apoptosis
in human cells [6, 7], but the identity of the protein/factor
responsible for the induction of apoptosis remains un-
known. In recent decades, it has also been established that
in many organisms cyt c plays an important role in apop-
tosis [8, 9]. During apoptosis, cyt c is released from the
mitochondria into the cytoplasm and binds to apoptosis
protease-activating factor-1 (Apaf-1) thus triggering a cas-
pase activation cascade [8]. For example, in humans, cyt c
can activate caspase-3 in cell-free activation assay [9]. The
first evidence of the existence of apoptosis in fungi came
from the study by Medeo et al. of a Saccharomyces cerevi-
siae mutant that showed signs of apoptosis [10]. Since then,
many homologous mammalian apoptotic proteins were dis-
covered in budding yeast [11]. In an important finding,
using deletion mutants which were unable to produce func-
tional cyt c, Silva et al. presented the first evidence that cyt
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c is involved in hyperosmotic stress induced yeast apoptosis
[12]. However, the nature of the role cyt c plays in apoptosis
of filamentous fungi like R. arrhizus remains unknown.
To characterize R. arrhizus cyt c, we cloned the gene
for cyt c from R. arrhizus in E. coli. The purified cyt c
was compared with two mammalian cyt c (horse and
human). We selected R. arrhizus cyt c as a candidate for
this study mainly for two reasons. First, this fungal cyt c
is distantly related to mammalian cyt c and its biochem-
ical properties are largely unknown.
Secondly, R. arrhizus is a pathogenic fungus and any
information gained on the pro-apoptotic activity of cyt c
may also contribute to the identification of better thera-
peutic targets. We found that cyt c of R. arrhizus has
similar biochemical properties to mammalian cyt c.
Results and discussion
A 19-fold purification was achieved for recombinant R.
arrhizus cyt c using a three step process involving ammo-
nium sulphate precipitation, cation exchange and gel fil-
tration chromatography (Fig. 1, Table 1). The purified
recombinant cyt c protein eluted from gel filtration col-
umn with absorption ratio 410/280 nm of >4.0 (Fig. 1b,
Table 1). Purity was also checked by SDS electrophoresis.
The eluted cyt c produced one band, which had an appar-
ent MW of ca. 14 kDa (Fig. 1c). Since this is the first re-
port on purification of recombinant R. arrhizus cyt c, we
compared our purification results with those reported by
others using similar plasmids. We obtained ~9 mg of cyt c
with a 410/280 ratio of >4 from 1 L of E. coli culture. Our
yield was similar to the reported yield for human cyt c of
>8 mg L−1 [13]. Patel et al. reported a yield of ~15 mg L−1
for horse cyt c [14]. However, in that work the authors
only performed a two-step purification (ammonium
sulphate precipitation and a cation exchange column)
[14]. Our yield was only marginally lower if we compare
our yield after the second purification step (Table 1).
In the case of the native R. arrhizus cyt c (protein iso-
lated form commercial preparation of lipase) the final pro-
tein eluted from a Superdex 75 column as a single peak
(Fig. 2a), but the 410/280 nm ratio was only 0.65. Efforts
to further purify the native protein using an additional
anion exchange column to trap impurities did not result
in any improvement.
This concurs with a previous study that reported diffi-
culties in purifying this protein from R. oryzae (syn. to
R. arrhizus) to high purity [15, 16]. The relative molecu-
lar weight determined for the native R. arrhizus cyt c by
SDS-PAGE was 12.55 ± 1.27 kDa (Fig. 2b) in agreement
with expectations for its molecular weight. Identity of
both, the native and the recombinant protein bands was
unequivocally confirmed by MALDI tandem mass spec-
troscopy (Fig. 3 and Additional file 1: Figure S1).
The UV–vis spectra of the oxidized native R. arrhizus
cyt c show peaks at 409 and 529 nm and in the reduced
state, α and β peaks are prominent at 549 and 520 nm,
respectively (Fig. 2c). Similar values were seen for the
recombinant R. arrhizus cyt c. These values are close to
other type-c cytochromes, thus suggesting a similar heme
environment (Table 2).
The presence of an absorption maximum at ~700 nm
in both recombinant and the native R. arrhizus ferri
cytochrome (Additional file 2: Figure S2A & B) suggests
that, like in other c-type cytochromes, methionine is one







 1     2        3    
Fig. 1 a Elution profile of recombinant R. arrhizus cyt c on a Hi-Trap SP Sepharose column (5 ml). The bound protein was eluted with an increasing
NaCl gradient over 7 column volumes. Peak fractions containing cyt c protein is indicated by *. b Elution profile of the pooled HiTrap SP Sepharose
peak fractions loaded onto a Superdex 200 GL column. Cyt c elution was followed using 410 nm absorption. Cyt c protein elutes as two unresolved
peaks (in inset peak 1 and 2). c Coomassie stained 15 % SDS-PAGE gel loaded (lane 1 and 2) with the peak 1 and 2 from the Superdex 200 GL column,
lane 3 =marker proteins. Cyt c band moves close to the 14 kDa marker band
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of the axial heme ligands. Additionally, sequence align-
ment shows that residues corresponding to Met-80 and
His-18 are conserved in 14 fungal cyt c [17], as well as
in human and horse cyt c.
The redox potential of native and recombinant R. arrhizus
cyt c was found to be similar to that of human and horse
cyt c, respectively, with no statistically significant difference
(Fig. 4 and Additional file 3: Figure S3). The redox potential
measurements for human and horse cyt c with 263.43 and
268.64 mV, respectively, were in close agreement with earlier
reported values validating our technique [18, 19]. The redox
potential measurements of native and recombinant R. arrhi-
zus cyt c were 266.90 and 270.04 mV and statistically the
same. These results further support structural similarity be-
tween the recombinant and native R. arrhizus cyt c proteins.
A major portion of cyt c remains loosely associated with
the inner mitochondrial membrane via ionic interactions
with the negatively charged mitochondrion-specific
phospholipid, cardiolipin. Kagan et al. had shown that car-
diolipin specific peroxidase activity of cardiolipin bound cyt
c may play an important role in triggering apoptosis by aid-
ing in the release of pro-apoptotic proteins, including cyt c,
from the matrix of the mitochondria [20]. Furthermore,
peroxidase activity assay provides an indirect measure of
heme accessibility and we therefore compared the peroxid-
ase activities of mammalian and R. arrhizus cyt c.
The peroxidase activity of native R. arrhizus cyt c was
found to be low compared to other known peroxidases,
which is a general characteristic of type-c cytochromes.
Recombinant cyt c showed a higher Kcat and Vmax com-
pared to native R. arrhizus cyt c. These variations are
most likely due to the higher purity of the recombinant
protein compared to native one (Table 2, Table 3). Also,
a high peroxidase activity could be related to partial
denaturation and thus a more accessible heme in the
non-recombinant cyt c. A partial denaturation can involve
the breaking of the methionine coordination that leaves
the heme more accessible for catalysis [21]. However, this
is ruled out by the UV-spectra of the recombinant cyt c
because they show the presence of the charge transfer
band thus indicating that methionine coordination is
intact (Additional file 2: Figure S2).
Native R. arrhizus cyt c showed similar activity as horse
cyt c while it was higher than human cyt c (Table 3). On
the other hand, judging from KM values the affinity of R.
arrhizus cyt c seems to be lower than human cyt c, and
very similar compared to horse cyt c (Table 3). The KM
value measured for horse cyt c was in close agreement
with Kim et al. [22] but varied from the one reported by
Randi et al. [23]. It is important to note that we used non-
linear regression to analyze the kinetics while the two
cited studies used Lineweaver-Burk plots, a method con-
sidered less reliable [24].
We noted the presence of the cyt c in good amounts
in a commercial preparation of a secreted lipase of R.
arrhizus (Fig. 2). Interestingly, in an earlier study, the
authors have indicated the presence of a “soluble factor”
Table 1 Purification of recombinant R. arrhizus cyt c








Lysate 43.9 ± 1.2 0.223 ± 0.005 100 1.00
Ammonium Sulphate
(Precipitation)
30.8 ± 0.7 0.306 ± 0.001 70.2 1.37
Dialysis 20.7 ± 0.2 0.440 ± 0.001 47.2 1.97
Cation exchange 12.4 ± 0.3 3.91 ± 0.10 28.2 17.50
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Fig. 2 a Elution profile of native R. arrhizus cyt c on a Superdex 75 column. b 15 % SDS PAGE gel showing the peak fraction (lane-1), Molecular
weight marker (lane-2). Band marked with an arrow indicate the position of protein band identified as cyt c. c Absorption spectra of the oxidized (—)
and reduced form (_) of the native R. arrhizus cyt c. The oxidized form shows a peak in the Soret region at 409 nm while in the reduced
form the Soret peak shifts to 415 nm
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in R. arrhizus extract that can activate caspase, but they
did not identify this factor [7]. Based on these observa-
tions, we tried to verify whether this unknown water-
soluble factor could be cyt c present in the supernatant
of the R. arrhizus cultures or not. Efforts to locate the
cyt c in supernatant fractions with heme staining (data
not shown) and using an antibody against cyt c were not
successful (Additional file 4: Figure S4). These results
suggest that under our test conditions, the protein is not
secreted into the supernatant. However, the possibilities
that the protein might be secreted in response to some
special cue, or in trace amounts, could not be ruled out.
Fig. 3 MS spectra of the recombinant Rhizopus cyt c and MS/MS spectra of native Rhizopus cyt c collected on a MALDI TOF/TOF instrument.
a MS spectra of the recombinant protein digested with trypsin. b MS/MS of precursor peptide (1166.67 Da) from the native R. arrhizus cyt c protein
digested with trypsin. Mascot online server was used to confirm the identity of both native and the recombinant proteins
Table 2 Comparison of the spectral properties of horse, human
and R. arrhizus cyt c
Cyt c αmax (nm) βmax (nm) α/β Charge transfer band (nm)
Horse 550 521 1.87 695
Human 549 520 2.86 695
nRhizopus 549 520 1.87 700
rRhizopus 549 520 1.87 699
nRhizopus: native cyt c from R. arrhizus; rRhizopus: recombinant cyt c from
R. arrhizus
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In the cell free caspase-3 activation assay, compared to
all cyt c tested, the recombinant R. arrhizus cyt c showed
the lowest activity. Its activity was similar to the negative
control, a cell lysate with asparaginase-II (Fig. 5). The na-
tive R. arrhizus cyt c showed a statistically significant (P <
0.05) higher caspase-3 signal but under the same condi-
tions no statistically significant difference was observed in
the signals of recombinant R. arrhizus cyt c and the nega-
tive asparaginase-II control (Fig. 5).
In our in vitro caspase-3 assay, we did not observe any
caspase-3 activity in the aqueous extracts prepared from
the R. arrhizus culture (Additional file 5: Figure S5). This
result indicate that the source of previously reported
activity in the aqueous extract is unlikely to be cyt c [7].
Compared to recombinant cyt c, higher caspase-3 acti-
vation by native R. arrhizus cyt c could be due to the
presence of other unidentified factor/s. Identity of these
factors is a matter of further investigation and beyond the
scope of the present study.
Additionally, the activation differences between native
R. arrhizus and the horse cyt c could be due to the
variations in distribution of positive patches on the R.
arrhizus cyt c surface, which are known to be critical
for cyt c/Apaf-1 interaction. Cyt c and Apaf-1 interact
through an extensive region. Many lysine residues (7, 8,
25, 39 and 72) spread across the surface of cyt c are
known to be important for this interaction. Disruption
of these residues by site directed mutagenesis has been
shown to abolish or lower the ability of horse and hu-
man cytochrome to activate caspases [25, 26]. In the
case of native R. arrhizus, the reduction in caspase-3
activation was seen when compared to horse cyt c. Se-
quence comparison with horse cyt c revealed that in
the native R. arrhizus cyt c two of these lysine residues
(7 and 25) are occupied by alanine (Fig. 6). We propose
that these changes to hydrophobic non-polar groups
(Ala) could decrease cyt c affinity for Apaf-1. The lower
caspase-3 activation by the native R. arrhizus cyt c is a
potential reflection of this effect. Indeed, these two
lysine residues (7 and 25) were demonstrated to be
essential for Apaf-1 binding, since a 10–100 fold drop
in caspase activity was observed by Yu et al. when these
amino acids were mutated in combination with other
Apaf-1 interacting residues in horse cyt c [25].
In Saccharomyces cerevisiae cyt c, a tri-methylation at
lysine 72 was attributed for being responsible for its lower
caspase activation potential [26]. We reasoned that it
is possible that a similar tri-methylation on the K72 in
Fig. 4 Peroxidase activity of native R. arrhizus cyt c as a function of
substrate (H2O2) concentration. Shown here is the amount of oxidized
ABTS (y-axis) formed per minute at different H2O2 concentrations
(X-axis). Error bars represent the standard deviation
Table 3 Kinetic parameters for the peroxidase activity of horse,
human and R. arrhizus cyt c
Cyt c KM (M) Vmax (mM min
−1) Kcat (min
−1)
Horse 23.0 ± 6.5 0.0541 ± 0.0091 22.0 ± 4.0
Human 3.74 ± 0.80 0.0190 ± 0.0020 7.60 ± 0.62
nRhizopus 20.1 ± 8.3 0.0434 ± 0.0093 29.0 ± 6.2
rRhizopus 13.12 ± 5.05 0.0892 ± 0.0203 59.47 ± 13.55
Results are the means ± S.D. of three readings
nRhizopus: native cyt c from R. arrhizus; rRhizopus: recombinant cyt c from
R. arrhizus
Fig. 5 Comparison of cell-free caspase-3 activation by horse, human
and R. arrhizus cyt c. Caspase-3 activation was followed at 405 nm and
normalized to the horse cyt c signal. rRA represents the recombinant
and nRA the native cyt c from R. arrhizus, while AspII represents the
negative control contains asparaginase-II (no cyt c). Each column
represents the mean of independent measurements, with error
bars representing the standard deviation. The initial incubation
to activate caspase was performed with samples at 10 μM final
concentration. The native cyt c signal (*) was significantly different from
the others (P < 0.05)
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R. arrhizus cyt c could also partly account for its lower
caspase activity as seen in our assays (Fig. 5). However,
our MALDI data does not support the presence of Lys-72
methylation (Additional file 6: Figure S6).
We also found four additional lysine substitutions in R.
arrhizus cyt c (K5A, K22E, K88A & K100E) that have not
been studied before, and could potentially contribute to
its reduced caspase-3 activation (Fig. 6). It will be interest-
ing to see if an R. arrhizus mutant with A7K and A25K
mutations shows increased caspase-3 activation to the
level similar to that of horse cyt c, since this would help to
elucidate the role of other lysine substitutions seen in R.
arrhizus cyt c.
Conclusions
We have reported here a comparative characterization
of R. arrhizus cyt c. To the best of our knowledge, this
is the first report on recombinant purification and bio-
chemical characterization of the R. arrhizus cyt c.
The mitochondrial proteins are attractive targets for
new antifungal drugs [27]. A better understanding of the
role of specific sequences in cyt c’s ability to induce apop-
tosis and its differences with mammalian cyt c could lead
to the identification of methods for exclusive targeting of
this fungal pathogen. It will be interesting to see if the
amino acid differences in cyt c of R. arrhizus could pro-
vide it with sufficient specificity to induce apoptosis exclu-
sively in fungal cells. If this turns out to be the case,
designing of fungi specific apoptosis inducing drugs may
be possible. Although results of targeting human cancer
cells by actively inducing apoptosis using mammalian cyt
c delivery have been promising [28, 29], replicating them
in the fungal cells could be very challenging due to the
presence of their cell wall. Our results show the ability of
R. arrhizus cyt c to activate caspase-3. This finding indi-
cates that this pathogen could potentially use a similar
mechanism in vivo to establish infections. To explore the
possibility of existence of such mechanism in vivo, a study
of clinical isolates and samples from infected patients
would be helpful. At present such studies are impeded by
the lack of our knowledge about the role of R. arrhizus cyt
c in apoptosis. This study will help catalyze exploration
into the possible involvement of cyt c in establishing
mucormycosis infections.
Methods
Gene cloning and protein purification
Recombinant R. arrhizus cyt c was expressed from a con-
struct made by modifying the pBTR1 plasmid [13]. pBTR1
was a gift from Gary Pielak (Addgene plasmid # 22468). It
Fig. 6 a Sequence alignment of R. arrhizus cyt c with human, horse, and budding yeast cyt c. The shaded areas are the residues (in horse) essentially
involved in Apaf-1 binding. Residues in R. arrhizus showing charge reversal/neutralization (with respect to horse Lys) substitutions are shown in green.
The numbering position of residues is with respect to horse cyt c. b Protein models of R. arrhizus and horse cyt c showing positions of 3 important
lysine residues involved in Apaf-1 binding. From left to right: R. arrhizus model (generated using Swiss-model homology modeling server) and horse
cyt c (PDB ID-1HRC). In R. arrhizus, two residues important for Apaf-1 binding, lysine 7 and 25 (red) are substituted by alanine. Another
important lysine residue (blue) is conserved in both R. arrhizus and horse cyt c. Both images were generated using PyMOL
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contained human cyt c gene and a heme lyase gene from
Saccharomyces cerevisiae. The lyase gene is essential for
heme incorporation into cyt c protein. In the modified
plasmid (pBRA), human cyt c was replaced with the gene
encoding R. arrhizus cyt c. The sequence coding for R.
arrhizus cyt c was commercially synthesized (GenScript)
and ligated into pBTR1 vector (without the human cyt c
gene) using Gibson Assembly (NEB). The primers utilized
and steps performed to obtain pBRA are provided in the
Additional file (primer and vector details are provided in
Additional file 7: Figure S7). pBRA was transformed into
BL21(DE3)T1R cells (Sigma). The bacterial cultures were
grown in TB media (12 gmL−1 tryptone, 24 gmL−1 yeast
extract, 8 mL glycerol, 2.3 gL−1 KH2PO4 and 12.5 gL
−1
K2HPO4) containing ampicillin (100 mgL
−1) at 37 °C
under constant shaking at 220 rpm. A 5 mL overnight cul-
ture grown from a single colony was used to inoculate a
500 mL culture. The culture was harvested after 18 h of
growth at 37 °C by centrifuging at 7000 g at 4 °C. The pel-
let obtained was incubated with lysozyme 3 gL−1 and
3 mg of DNase 1 in lysis buffer (50 mM Tris-Cl pH 6.8
and 1 mM EDTA) for 8 h at 4 °C with stirring. The lysis
mixture was sonicated on ice for 5 min. Lysed cells were
centrifuged at 7000 g on a Sorvall RC 6 plus (Thermo
Scientific) at 4 °C. Ammonium sulfate was added slowly to
the supernatant at 4 °C under constant stirring to a final
concentration of 350 gL−1. The resulting precipitate was
centrifuged at 7000 g for 30 min at 4 °C. The supernatant
containing cyt c was dialyzed using a 3.5 kDa dialysis
membrane overnight against 20 mM sodium phosphate
buffer at pH 6.8. Dialyzed protein was loaded on a HiTrap
SP Sepharose column (GE Healthcare) equilibrated with
buffer A (40 mM sodium phosphate buffer at pH 6.8).
Bound protein was eluted with elution buffer B (40 mM
sodium phosphate at pH 6.8 and 1 M NaCl) using a linear
gradient from 0 % B to 100 % B over a 7 column volume.
Peak fractions with an absorbance ratio of 410/280 nm >
2.5 were pooled and loaded on a Superdex 200 gel filtra-
tion column (GE Healthcare). Protein elution from the
Superdex 200 column was followed by absorption at 410
and 280 nm. Peak fractions were analyzed by loading onto
a 15 % SDS-PAGE. Native R. arrhizus cyt c was purified
using lipase of R. arrhizus obtained from Sigma using a
similar scheme as that of the recombinant protein.
Human and horse cyt c were used as controls in all
the assays performed unless otherwise stated. Human
cyt c was expressed in E. coli using plasmid pBRT1 and
purification was done as described by Olteanu et al. [13].
Horse heart cyt c was purchased from Sigma and used
without further purification.
UV–vis spectroscopy
All spectra were measured using a UV–Vis NanoDrop
2000/2000c (Thermo Scientific) spectrophotometer except
for the charge transfer band (CTB). The CTB region was
measured on a UV-2450 Shimadzu spectrophotometer,
with a slit width of 0.5 nm. The peak location was deter-
mined by using the picking algorithm of the UV-Probe
2.33 software (Shimadzu).
Trypsin digestion and mass spectrometry
In-gel trypsin digestion was performed using 500–1000 ng
of both native and recombinant R. arrhizus cyt c as de-
scribed [30]. In brief, the gel-eluted peptides resulting
from trypsin digestion were first vacuum dried and later
purified on a C18 reverse phase tip column (Millipore)
using the instructions supplied by the manufacturer.
Trypsin-digested peptides were eluted in a total volume of
5 μl of acetonitrile and 0.1 % trifluoro acetic acid solution
(50:50 v/v). The purified peptides were directly spotted
onto the MALDI plate following the dried droplet method
[31]. The matrix solution used contained 5 mg/mL α-
cyano-4-hydrooxycinnamic acid (HCCA, Sigma) in aceto-
nitrile and 0.1 % trifluoro acetic acid (50:50 v/v). Tandem
mass spectrometric analysis was performed using an
ABSCIEX 4800 Plus MALDI TOF/TOF™ Analyzer in Top
6 mode. The spectra were collected in positive ion re-
flector mode with 500–1000 laser shots per spectrum.
Protein identification was performed using the Mascot
server (Matrix Science, http://www.matrixscience.com/
search_form_select.html).
Redox potential
The redox potential of R. arrhizus cyt c was determined as
described [18] with some minor modifications. Briefly,
100 mM stock solutions of potassium ferrocyanide (fer-
roCN), potassium ferricyanide (ferriCN), and (+)-sodium
L-ascorbate were prepared in 100 mM potassium phos-
phate buffer at pH 7.0. Prior to use, all solutions were vac-
uum degasified and purged with nitrogen for 2–3 min.
The absorbance of samples was recorded at 550 nm using
a NanoDrop 2000/2000c spectrophotometer (Thermo
Scientific). A plot of log([ferroCN]/[ferriCN]) vs. log([fer-
rocyt c]/[ferricyt c]) was drawn using Prism 5 (GraphPad
Software).
Peroxidase assay
Cyt c peroxidase activity was measured as described [22].
Briefly, each reaction was performed in a total reaction
volume of 150 μL with 50 μM 2,2′-azino-bis(3-ethylben-
zothiazoline-6-sulphonic acid) (ABTS), 2.5 μM for human
and horse cyt c, and 1.5 μM for native R. arrhizus cyt c.
The concentration of cyt c was determined using the
absorption coefficient of 29.5 mM−1 cm−1 at 550 nm [32].
Each reaction was followed for 40 s by recording the
absorption of oxidized ABTS at 405 nm. The concentra-
tion of oxidized ABTS was calculated using the extinction
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coefficient of 36.8 mM−1 cm−1 at 405 nm. For each reac-
tion with varying H2O2 concentrations (ranging from 1.0
to 28 mM), initial rates were measured using the linear
part of the absorption curve. All absorption readings were
made using a Shimadzu UV-2450 spectrophotometer
using a cell of 1 cm path length at 25 °C. The Michaelis-
Menten constants KM, Kcat and Vmax were determined by
nonlinear regression curve fitting using Prism 5 (Graph-
Pad Software).
Cell free caspase-3 activation assay
HeLa cells were grown to 90 % confluency, harvested,
and disrupted as described [29]. Prior to disruption,
approximately a total of 2 × 107 cells were suspended in
2 mL of lysis buffer consisting of 20 mM HEPES at
pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM Na-EDTA,
1 mM Na-EGTA, 1 mM DTT, 250 mM sucrose, and
0.1 % v/v protease inhibitor cocktail (2 mM AEBSF,
0.3 μM aprotinin, 130 μM bestatin, 14 mM E-64, 1 mM
leupeptin, 1 mM EDTA). The HeLa cell extract (lys-
ate) was stored at −80 °C for at least 5 days before
use. Total protein content in the lysate was deter-
mined by the Bradford method. Each cyt c sample
was incubated with the lysate in a total volume of
50 μL at 37 °C for 1 h using a Mastercycler (Eppen-
dorf ). This incubation mixture consisted of 1 mM
dATP, 4 mg/mL total protein from lysate, and 10 μM
cyt c; cyt c concentration was determined using the
absorption coefficient 29.5 mM−1 cm−1 at 550 nm
[32]. Immediately thereafter, caspase-3 activation was
performed as per the manufacturer’s protocol (CaspACE™
Colorimetric Assay System, G7220). Briefly, 20 μL from
the incubation mixture was added to 78 μL of a mixture
containing 128.2 mM HEPES at pH 7.5, 12.82 %w/v su-
crose, 0.1282 %w/v CHAPS, 2.56 % v/v DMSO, and
12.8 mM DTT. Afterwards, 2 μL of 10 mM caspase-3 sub-
strate (Ac-DEVD-pNA) was added. The plate was incu-
bated overnight, and the absorbance measured at 405 nm
using a microplate reader (BioTek-Synergy H1 Hybrid
Reader). All measurements were performed in triplicate.
The activation by horse cyt c was considered 100 %, and
other results were normalized relative to horse cyt c. In
these assays, a negative control that contained HeLa cell
lysate with asparaginase-II, an unrelated non-apoptotic
protein, was used. Asparaginase-II was purified from E.
coli as described earlier [33]. Additionally, an aqueous ex-
tract of R. arrhizus was also made and tested for caspase-3
activation (Additional file 5: Figure S6).
Availability of supporting data
The data supporting the results of this article is included
within the article in seven additional files.
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